Radiopharmaceutical Therapies Market Size, Share, By Radioisotope Type (Iodine-131, Gallium-68, Technetium-99m, Zirconium 89, Copper 64, Radium 223, Fluorine 18, Lutetium-177, Rubidium-82, Indium-111, and Others), By Source (Nuclear Reactors, Cyclotrons,
Description
In 2023, radiopharmaceuticals therapies market was estimated to be worth USD 15.32 Billion.
By 2034, the target market is expected to grow to USD 27.3 Billion.
Target market is expanding at a CAGR of 6.6%
radiopharmaceutical therapies market involves gathering, analyzing, and interpreting information about a market, including its consumers, competitors, and overall industry trends. It helps businesses understand their target audience, identify opportunities for growth, and make informed decisions about product development, marketing strategies, and business expansion. radiopharmaceutical therapies market methods can include surveys, interviews, focus groups, and data analysis to uncover insights that drive business success.
Key Industry Insights
Based on the market type, major players, on-premises availability, and applications, this study was put up. The main product and application categories as well as important market segments for radiopharmaceutical therapies market have been covered in this study. Additionally, it computes each segment's growth over the projected period. A few statistics about the forenamed market support the report. The report includes vital information on the significant aspects that are expected to be present during the forecast period and their effects on the growth of the market.
Research Methodology:
Prophecy Market Insights follows a follows a structured four-step Methodology in all its reports.
Step 1: Key Variables Identification:
To create a robust research methodology, we first identify the important variables and factors, which influence the market. These variables are then tested against the historical data. Via an iterative process, the relevant variables are selected and the methodology is created based on these key factors.
Step 2: Market Model Development:
Prophecy Market Insights predict the market size for the projected years in nominal terms. The average selling price (ASP) is kept constant and inflation is excluded during the forecast period for each country.
Step 3: Validation and Finalization:
In this step, all market variables, data, and analyst insights are validated via a comprehensive primary research network. Experts from different functions and levels within the market are consulted for ensuring an accurate understanding of the market dynamics.
Step 4: Research Outputs Delivery:
The final results include the custom consulting projects, subscriptions platforms, syndicated reports, and databases, providing actionable insights to our clients.
Gain insights into the radiopharmaceutical therapies market’s forecast for 2025 to 2035, covering the market size, revenue growth, and share. Prophecy Market Insights offers an in-depth analysis, such as market projections and historical projections for the 2025-2035. Download a free sample report for an overview of the market.
Competitive Dashboard
The research includes intricate details about the contributions made by major companies, a review of supply and demand, and the rise in radiopharmaceutical therapies 's market share. The major players in the radiopharmaceutical therapies market are evaluated in-depth using factors such as organization financial standing, production volume, product description, and profiling. Their business plans, SWOT analysis, revenue share, developments, and other data are also included in this part. To maintain a sizable market share, the top businesses employ a variety of tactics, including partnerships, collaborations, mergers and acquisitions, and new product releases.
This report includes the development trends, sales channel research, upstream raw material analysis, and downstream demand analysis. The research study predicts if a product will be profitable for the company. Such forecasts would help industry participants introduce new goods and grow their businesses in the radiopharmaceutical therapies market sector.
radiopharmaceutical therapies market Key Companies
By Radioisotope Type:
The post emphasizes the regional study that looks at several areas that are fueling the radiopharmaceutical therapies market's expansion. Regional trends that may have an impact on growth during the predicted period are also taken into consideration. The sales, revenue, price, and gross margin of various regions' markets are estimated in the geographical overview. This research report also includes microeconomic aspects that impact market growth in each area.
FAQs:
Key Questions Answered in the Report.
1. What was the radiopharmaceutical therapies market size in 2024?
2. What is projected growth rate of the radiopharmaceutical therapies market during 2025-2035?
3. What are the key factors driving the market growth?
4. What are leading players in the radiopharmaceutical therapies market?
5. What are the key regions analyzed in the radiopharmaceutical therapies market?
6. Which region is dominating in the market?
By 2034, the target market is expected to grow to USD 27.3 Billion.
Target market is expanding at a CAGR of 6.6%
radiopharmaceutical therapies market involves gathering, analyzing, and interpreting information about a market, including its consumers, competitors, and overall industry trends. It helps businesses understand their target audience, identify opportunities for growth, and make informed decisions about product development, marketing strategies, and business expansion. radiopharmaceutical therapies market methods can include surveys, interviews, focus groups, and data analysis to uncover insights that drive business success.
Key Industry Insights
Based on the market type, major players, on-premises availability, and applications, this study was put up. The main product and application categories as well as important market segments for radiopharmaceutical therapies market have been covered in this study. Additionally, it computes each segment's growth over the projected period. A few statistics about the forenamed market support the report. The report includes vital information on the significant aspects that are expected to be present during the forecast period and their effects on the growth of the market.
Research Methodology:
Prophecy Market Insights follows a follows a structured four-step Methodology in all its reports.
Step 1: Key Variables Identification:
To create a robust research methodology, we first identify the important variables and factors, which influence the market. These variables are then tested against the historical data. Via an iterative process, the relevant variables are selected and the methodology is created based on these key factors.
Step 2: Market Model Development:
Prophecy Market Insights predict the market size for the projected years in nominal terms. The average selling price (ASP) is kept constant and inflation is excluded during the forecast period for each country.
Step 3: Validation and Finalization:
In this step, all market variables, data, and analyst insights are validated via a comprehensive primary research network. Experts from different functions and levels within the market are consulted for ensuring an accurate understanding of the market dynamics.
Step 4: Research Outputs Delivery:
The final results include the custom consulting projects, subscriptions platforms, syndicated reports, and databases, providing actionable insights to our clients.
Gain insights into the radiopharmaceutical therapies market’s forecast for 2025 to 2035, covering the market size, revenue growth, and share. Prophecy Market Insights offers an in-depth analysis, such as market projections and historical projections for the 2025-2035. Download a free sample report for an overview of the market.
Competitive Dashboard
The research includes intricate details about the contributions made by major companies, a review of supply and demand, and the rise in radiopharmaceutical therapies 's market share. The major players in the radiopharmaceutical therapies market are evaluated in-depth using factors such as organization financial standing, production volume, product description, and profiling. Their business plans, SWOT analysis, revenue share, developments, and other data are also included in this part. To maintain a sizable market share, the top businesses employ a variety of tactics, including partnerships, collaborations, mergers and acquisitions, and new product releases.
This report includes the development trends, sales channel research, upstream raw material analysis, and downstream demand analysis. The research study predicts if a product will be profitable for the company. Such forecasts would help industry participants introduce new goods and grow their businesses in the radiopharmaceutical therapies market sector.
radiopharmaceutical therapies market Key Companies
- Bayer AG
- Cardinal Health
- Eli Lilly and Company
- Lantheus
- Novartis AG
- Bracco
- Jubilant Draximage Radiopharmacies Inc
- Eckert & Ziegler
- IBA Radiopharma Solutions
- Mallinckrodt
- NMR
- NTP
- PharmaLogic.
- All segments of the global radiopharmaceutical therapies market have been evidently enclosed in this study
- The report highlights the competitive status of key players within the forecast timeline while focusing on their portfolio and regional expansion
- The research report extensively segments the geographical overview of radiopharmaceutical therapies market industry
- The report comprises a detailed assessment of the competitive terrain of this vertical.
- The report provides a market dynamics scenario, along with growth opportunities in the years to come.
By Radioisotope Type:
- Iodine-131
- Gallium-68
- Technetium-99m
- Zirconium-89
- Copper-64
- Radium-223
- Fluorione-18
- Lutetium-177
- Rubidium-82
- Indium-111
- Others
- Nuclear Reactors
- Cyclotrons
- Others
- Oncology
- Cardiology
- Gastroenterology
- Neurology
- Nephrology
- Others
- Hospitals
- Diagnostic Centers
- Cancer Research Institutes
- Ambulatory Surgical Centers
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
The post emphasizes the regional study that looks at several areas that are fueling the radiopharmaceutical therapies market's expansion. Regional trends that may have an impact on growth during the predicted period are also taken into consideration. The sales, revenue, price, and gross margin of various regions' markets are estimated in the geographical overview. This research report also includes microeconomic aspects that impact market growth in each area.
FAQs:
Key Questions Answered in the Report.
1. What was the radiopharmaceutical therapies market size in 2024?
2. What is projected growth rate of the radiopharmaceutical therapies market during 2025-2035?
3. What are the key factors driving the market growth?
4. What are leading players in the radiopharmaceutical therapies market?
5. What are the key regions analyzed in the radiopharmaceutical therapies market?
6. Which region is dominating in the market?
Table of Contents
189 Pages
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Radioisotope Type
- Market Snippet, By Source
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Product Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Advantages for Special Imaging Tests
- Widespread Usage for Treating Certain Types of Cancers
- Clinical Trials for Cancer Treatment
- Market Segmentation, By Radioisotope Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Iodine-131
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Gallium-68
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Technetium-99m
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Zirconum-89
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Copper-64
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Radium-223
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Fluorine-18
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Lutetium-177
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Rubidium-82
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Indium-111
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Source, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Nuclear Reactors
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cyclotrons
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Application, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cardiology
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Gastroenterology
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Neurology
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Nephrology
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By End User, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Diagnostic Centers
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cancer Research Institutes
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (USD Bn), By Radioisotope Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- U.S
- Canada
- Asia Pacific
- Market Size and Forecast (USD Bn), By Radioisotope Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Europe
- Market Size and Forecast (USD Bn), By Radioisotope Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- UK
- Germany
- France
- Russia
- Italy
- Rest of Europe
- Latin America
- Market Size and Forecast (USD Bn), By Radioisotope Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- Market Size and Forecast (USD Bn), By Radioisotope Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East and Africa
- Competitive Landscape
- Bayer AG
- Cardinal Health
- Eli Lilly and Company
- Lantheus
- Novartis AG
- Bracco
- Jubilant Draximage Radiopharmacies, Inc.
- Eckert & Ziegler
- IBA Radiopharma Solutions
- Mallinckrodt
- NMR
- NTP
- PharmaLogic.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
